Location permission needed for a better experience.
How can we help you?
EN
Hızlı Randevu
Hastane
Randevusu
Görüntülü Görüşme Randevusu
Education
  • 2022 Avrupa Meme Görüntüleme Diploması (European Diploma in Breast Imaging-EDBI)
  • 2021 İstanbul Medipol University Uluslararası Faculty of Medicine / Radyoloji Professor
  • 2016 Atatürk University Health Sciences Institute/Anatomi Doktora
  • 2015 Atatürk University Faculty of Medicine / Radyoloji Associate Professor
  • 2008 Atatürk University Faculty of Medicine Radyoloji
  • 2002 Hacettepe University Faculty of Medicine
Experience
  • 2025 Acıbadem Healthcare Services
  • 2019 İstanbul Medipol University-Mega Üniversite Hospital
  • 2016 Dışkapı Yıldırım Beyazıt Eğitim ve Araştırma Hospital
  • 2010 Atatürk University Faculty of Medicine Radyoloji
  • 2009 Kars Devlet Hospital
  • 2008 Yozgat Devlet Hospital
  • 2002 - 2008 Atatürk University Faculty of Medicine Radyoloji Uzmanlık Eğitimi
Memberships
  • European Society of Radiology
  • Erzurum Meme Hastalıkları Association
  • Türk Radyoloji Association
  • Türk Manyetik Rezonans Association
  • Ankara Meme Hastalıkları Association
  • The European Society of Magnetic Resonance in Medicine and Biology
  • Europan Society of Breast Imaging
  • İstanbul Tabip Odası
PUBLICATIONS
  • Can artificial intelligence detect type 2 diabetes in women by evaluating the pectoral muscle on tomosynthesis: diagnostic study. Insights Imaging. 2024;15(1):99. Yashar M, Izci IB, Gungoren FZ, Eren A, Mert A, Durur-Subasi I.
  • Artificial Intelligence in Breast Imaging: Opportunities, Challenges, and Legal-Ethical Considerations. Eurasian J Med. 2023;55(1):114-119. Subasi ID, Özçelik ŞB.
  • Management of granulomatous lobular mastitis: an international multidisciplinary consensus (2021 edition) [published correction appears in Mil Med Res. 2022 Aug 23;9(1):47. doi: 10.1186/s40779-022-00408-w.]. Mil Med Res. 2022;9(1):20. Yuan QQ, Xiao SY, Farouk O, Du YT, Sheybani F, Tan QT, Akbulut S, Cetin K, Alikhassi A, Yaghan RJ, Durur-Subasi I, et al.
  • Does the cardiovascular drug levosimendan prevent iodinated contrast medium nephrotoxicity with glycerol aggravation in rats?. Eur Radiol Exp. 2021;5(1):49. Durur-Subasi I, Kose D, Yayla M, et al.
  • Mass and non-mass breast MRI patterns: a radiologic approach to sick lobe theory Acta Radiol. 2021;62(6):715-721 Guven S, Durur-Subasi I, Demirci E, et al.
.
.
.

Contact Us

Fill out the form below for your information requests

As Acıbadem Healthcare Group, you can report your requests, suggestions, thanks and complaints by filling out the form below or by contacting us at +90 538 685 39 52 so that we can provide you with a better and higher quality service.

See More
See More
Security Code

INFORMATION NOTICE ON THE PROCESSING OF PERSONAL DATA

Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. and its controlling and affiliated companies listed in Annex-1 (each referred to individually as the "Company" and collectively as the "Companies") process your general and/or special category personal data (including but not limited to health data) ("Personal Data") in the capacity of Data Controller under the Personal Data Protection Law No. 6698 ("Law") and related legislation. Processing of Personal Data is carried out in accordance with the framework outlined below and in compliance with the Fundamental Law on Health Services No. 3359, the Decree Law No. 663 on the Organization and Duties of the Ministry of Health and its Affiliated Institutions, the Regulation on the Provision of Remote Health Services, the Private Hospitals Regulation, the Ministry of Health regulations, and other relevant legislation.

I. Acquisition, Processing, and Purposes of Processing Personal Data

Your Personal Data is obtained through verbal, written, visual, or electronic channels (such as our website, mobile applications, and call center) for the purposes of protecting public health, preventive medicine, medical diagnosis, treatment and care services, and the planning and management of healthcare services and their financing, in alignment with the Company's fields of activity. The Personal Data processed by the Company, including but not limited to the following, is collected and processed proportionally and in connection with these purposes:

Your Personal Data may be processed under the conditions specified in Articles 5 and 6 of the Law for the following purposes:

II. Transfer of Personal Data

Your Personal Data may be shared with:

III. Method and Legal Basis for Collecting Personal Data

Your Personal Data is collected through verbal, written, visual, or electronic means for the lawful execution of the Company's activities and compliance with contractual and legal obligations. The legal basis for collection includes:

As per Article 6 - (3) of the Law, personal data related to health and sexual life may be processed without explicit consent by persons or institutions subject to confidentiality obligations for public health protection, preventive medicine, medical diagnosis, treatment, and care services, as well as the planning and management of healthcare financing.

IV. Your Rights Regarding the Protection of Personal Data

Under Article 11 of the Law, you have the right to:

V. Data Security

The Companies ensure the security of Personal Data by implementing necessary technical and administrative measures in accordance with information security standards and procedures.

VI. Complaints and Contact Information

To exercise your rights under the Law, you may submit a request through the methods specified in the "Acıbadem Sağlık Hizmetleri ve Ticaret A.Ş. Data Subject Application Form" available at https://www.acibadem.com.tr/acibademonline/images/Ac%C4%B1badem_Veri_Sahibi_Basvuru_Formu.pdf.

Requests can be submitted by mail, notarized document, or secure electronic means to:

ANNEX-1: List of Companies

 

TOP x""